Dr. Paul Featured on Mondays with Michael — A Conversation on Informed Consent and Vaccine Risk Assessment
An in-depth discussion on medical training, informed consent, vaccine study design, and evaluating risk during pregnancy and childhood.
Dr. Paul recently joined Dr. Michael Gaeta on
Mondays with Michael (Show 301, February 2, 2026) for a wide-ranging conversation on medical education, vaccine safety research, and the ethical foundations of informed consent .
The full interview is available on the
Mondays with Michael homepage:
https://michaelgaeta.com/mwm/
During the interview, Dr. Paul reflects on his conventional medical training and how vaccine safety and efficacy were presented as settled science during his education . He describes a turning point in the early 2000s after attending a Defeat Autism Now conference and later witnessing developmental regression in children within his own practice .
The discussion explores how vaccine safety studies are structured, including concerns raised in the interview about placebo use, study duration, outcome selection, and statistical framing . Dr. Paul emphasizes the importance of evaluating both risks and benefits, rather than relying solely on generalized assurances.
He also discusses pregnancy considerations, immune activation, and his perspective on how families can approach vaccine decision-making through careful review of data. His book,
VAX Facts, is referenced as a resource intended to help families understand the science behind each vaccine on the childhood schedule . (Available at
https://vaxfactsbook.com/)
Key Points Discussed
- Medical Education and Information Framing
Dr. Paul explains that during his training, vaccines were presented as safe and effective without detailed discussion of ingredients or long-term comparative studies . - Observations from Clinical Practice
He recounts observing developmental regression in several children between 2004 and 2008, which prompted him to reevaluate assumptions about vaccine safety . - Study Design Concerns
The interview examines concerns about placebo controls, duration of trials, selective outcome reporting, and what Dr. Paul describes as “tobacco science” parallels in research methodology . - Informed Consent
Dr. Paul discusses how true informed consent requires presenting risks and benefits transparently, rather than offering simplified reassurances . - COVID mRNA Products
He distinguishes mRNA COVID products from traditional vaccines and shares concerns about safety and risk framing . - HPV, Hepatitis B, and Hepatitis A
Dr. Paul outlines his concerns regarding these vaccines as discussed in the episode, including risk–benefit comparisons and clinical observations . - Pregnancy and Immune Activation
The conversation includes discussion of immune activation during pregnancy and how relative risk should be considered when evaluating interventions . - Relative Risk Evaluation
Dr. Paul emphasizes comparing disease prevalence and severity with vaccine-associated risk when making decisions .
“For every vaccine on the childhood schedule, you are more likely to be harmed by the vaccine than by not vaccinating.” — Dr. Paul
#WithTheWind, #DrPaul, #MondaysWithMichael, #MichaelGaeta, #VAXFacts, #InformedConsent, #VaccineEducation, #MedicalFreedom, #PediatricPerspectives, #HealthFreedom, @DrMichaelGaeta, @MondaysWithMichael, @KidsFirst4Ever
Disclaimer
The information shared in this interview is presented for educational and informational purposes only. It is not intended as medical advice and does not establish a doctor–patient relationship. Always consult a qualified healthcare professional regarding medical decisions.